Market Overview

UPDATE: Stifel Nicolaus Initiates Stryker Corporation at Buy on Valuation

Related SYK
Brean Digs Into Osiris Therapeutics 10Q, Downgrades To Sell
Earnings Scheduled For October 22, 2015
Do Not Strike Stryker Out (Seeking Alpha)

Stifel Nicolaus initiated coverage on Stryker Corporation (NYSE: SYK) with a Buy rating and a $65 price target.

Stifel Nicolaus noted, "The recent appointment of CEO, Kevin Lobo, formerly head of Stryker's Reconstructive Products Division, ends an extended period of leadership uncertainty. … On an absolute basis, SYK trades at 12.2x and 6.5x our 2013 EPS and EBITDA (EV/EBITDA) estimates, respectively. These current multiples represent discounts to the average SYK P/E and EV/EBITDA multiples, since 2009, of 13.8x and 8.0x, respectively."

Stryker Corporation closed at $52.10 on Monday.

Latest Ratings for SYK

Nov 2015Goldman SachsDowngradesBuyNeutral
Nov 2015CitigroupInitiates Coverage onSell
Nov 2015Sterne Agee CRTInitiates Coverage onNeutral

View More Analyst Ratings for SYK
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Initiation Intraday Update Analyst Ratings


Related Articles (SYK)

View Comments and Join the Discussion!

Get Benzinga's Newsletters